The Value of CD23 Expression as an Additional Marker in Distinguishing Mediastinal (Thymic) Large B-Cell Lymphoma From Hodgkin Lymphoma
Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Sherrie L. Perkins(University of Utah), Sheryl R. Tripp(University of Utah), Kedar Inamdar(Henry Ford Hospital), Malaiyalam Mariappan(Yale University)
Cited by 36
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441